Core Viewpoint - OGAWA Intelligent Health Technology Group has showcased its strategic positioning and development in the health industry through recent investor meetings, highlighting its focus on health products and market potential [1] Group 1: Business Overview - The company primarily operates in health massage products, including massage chairs and small massage appliances, as well as health environment products like fresh air systems and air purifiers. In the first half of 2025, the revenue contribution from massage chairs, small massage appliances, health environment, and other categories was 44.23%, 30.64%, 15.30%, and 9.83% respectively [2] - The market potential is significant, particularly in East Asia and Southeast Asia, where traditional massage practices are prevalent. Developed regions like North America and Europe have also begun to recognize the health benefits of these products. The domestic market for massage health products has low penetration and concentration, indicating substantial growth potential as health demands rise and the population ages [2] Group 2: Financial Performance and Strategy - The company has experienced a decline in revenue and net profit due to global economic slowdown and weak consumer demand. However, it has implemented several strategies to enhance performance, including focusing on the health industry, increasing the share of its own brand revenue to over 50%, and achieving significant growth in the "OGAWA" brand [3] - The company is investing in technological innovation, particularly in AI technology and product development, with the introduction of a globally pioneering 5D core technology in high-end massage chairs. It is also expanding its marketing efforts and enhancing online competitiveness through targeted advertising and influencer collaborations [3] Group 3: Production and Innovation - The company’s factory in Vietnam has a production capacity of 5.4 million units per year for small massage appliances and health environment products, catering to overseas ODM clients. The company plans to adjust production based on market conditions [4] - In the AI sector, the company is developing a matrix of innovative technologies and smart products, including precise detection of massage intensity and adaptive control. It is also working on health service robots and new massage chair designs that feature advanced movement capabilities [4] Group 4: Financial Instruments - As of June 30, 2025, the remaining balance of the convertible bonds "OGAWA Convertible Bonds" was 458 million yuan, which is classified as a current liability due to its maturity in February 2026. The company has decided not to adjust the conversion price for the next six months [4]

Core Viewpoint - The China Convertible Bond Index opened down by 0.07%, indicating a slight decline in the market sentiment towards convertible bonds [1] Summary by Category Market Performance - The China Convertible Bond Index reported a value of 447.15 points at the opening [1] - Notable declines were observed in several convertible bonds, with Electric Chemical Convertible Bond down by 4.46%, Jing 23 Convertible Bond down by 3.77%, Titan Convertible Bond down by 2.54%, Ling Steel Convertible Bond down by 1.52%, and Ojia Convertible Bond down by 1.46% [1] - Conversely, some convertible bonds experienced gains, with Jiuzhou Convertible Bond 2 up by 5.66%, New Port Convertible Bond up by 5.60%, Daotong Convertible Bond up by 2.66%, Saili Convertible Bond up by 2.37%, and Hongtu Convertible Bond up by 2.26% [1]

Core Viewpoint - The article discusses various companies' stock movements, including share transfers and bond adjustments, indicating potential investment opportunities and market trends [1]. Group 1: Share Transfers - Aotewei's controlling shareholder plans to transfer 4.99% of the company's shares [1]. - The controlling shareholder of Yirui Bio intends to reduce their holdings by no more than 3% [1]. - The consistent action party of Aerospace Hongtu plans to transfer 5.1% of shares to a private equity fund [1]. - Guolian Aviation's shareholder intends to reduce their holdings by no more than 1% [1]. Group 2: Convertible Bonds - Qilu Convertible Bond is subject to strong redemption [1]. - Qibin Convertible Bond has been adjusted down to the lowest level [1]. - Several convertible bonds, including Tian Nai, Tai 21, Jing Neng, Changqi, Jin Neng, and Oujia, will not undergo adjustments [1]. - Guangneng Convertible Bond is set for subscription on July 9 [1]. Group 3: New Stock Offerings - Huadian New Energy is listed for subscription on the Shanghai and Shenzhen stock exchanges [1]. - Two REITs, Huaxia Huadian Clean Energy REIT (508016) and Chuangjin Hexin Shounong REIT (508039), are available for subscription [1].

Group 1 - The company has issued 12 million convertible bonds, known as "Aojia Convertible Bonds" (bond code: 128097), which were listed on March 18, 2020 [1][2] - The adjustment of the conversion price for the convertible bonds will occur based on specific corporate actions such as stock dividends, capital increases, and cash dividends [1][2] - The conversion price before adjustment is 9.45 CNY per share, and the adjusted conversion price will be 9.35 CNY per share, effective from May 29, 2025 [3] Group 2 - The company will distribute a cash dividend of 1.00 CNY (including tax) for every 10 shares based on the total share capital of 623,476,857 shares [2] - The conversion period for the "Aojia Convertible Bonds" is from September 2, 2020, to February 25, 2026 [3]

Core Points - The company has announced its profit distribution plan for the fiscal year 2024, which includes a cash dividend of RMB 1.00 for every 10 shares held, with no bonus shares or capital reserve conversion [1][2] - The total share capital of the company is 623,476,857 shares, and the cash dividend will be distributed based on this figure [2][3] - The record date for the distribution is set for May 28, 2025, and the ex-dividend date is May 29, 2025 [3] Profit Distribution Plan - The profit distribution plan specifies that shareholders will receive RMB 1.00 per 10 shares, with different tax treatments for various types of shareholders [2][3] - For Hong Kong market investors and certain foreign institutions, the cash dividend will be RMB 0.90 per 10 shares due to tax considerations [2] - The company will not withhold individual income tax at the time of distribution; instead, it will be calculated based on the holding period when shares are sold [3] Convertible Bond Adjustments - The company's convertible bonds, known as "Aojia Convertible Bonds," will have their conversion price adjusted from RMB 9.45 to RMB 9.35 per share following the profit distribution [3][4] - This adjustment will take effect on May 29, 2025, after the completion of the profit distribution [3]

Core Viewpoint - The announcement details the issuance and conversion status of the convertible bonds of Aojiahua Intelligent Health Technology Group Co., Ltd, including adjustments to the conversion price and the current status of the company's shares [1][2][3][4][5]. Convertible Bond Issuance - The company issued 12 million convertible bonds with a total value of 1.2 billion RMB, each with a face value of 100 RMB, approved by the China Securities Regulatory Commission [1]. - The bonds were listed and began trading on March 18, 2020, under the name "Aojia Convertible Bonds" with the code "128097" [2]. Conversion Price Adjustments - The conversion price of the bonds has been adjusted multiple times due to cash dividends, with the latest adjustment reducing the price from 9.75 RMB to 9.45 RMB effective from May 29, 2024 [3][4]. Conversion and Share Changes - The conversion period for the bonds is from September 2, 2020, to February 25, 2026 [5]. - As of March 31, 2025, the remaining balance of convertible bonds is approximately 458.27 million RMB (4,582,702 bonds), and the total share capital has increased from 623,476,647 shares to 623,476,752 shares due to the conversion [5].